Encontrados 2130069 resultado(s)
Encontradas 21301 página(s)
Encontradas 21301 página(s)
Real-life management of patients with breakthrough cancer pain caused by bone metastases in Spain
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Albiach, CF, Estevez, FV, Alarcon, MDL, de Madariaga, M, Carregal, A, Arranz, J, Martin-Arroyo, JMT, Lopez, AJJ, Yague, AS
Purpose: We aimed to explore the characteristics, and real-life therapeutic management of patients with breakthrough cancer pain (BTcP) caused by bone metastases in Spain, and to evaluate physicians' opinion of and satisfaction with prescribed BTcP therapy.
Participants and methods: For the purposes of this study, an ad-hoc questionnaire was developed consisting of two domains: a) organizational aspects and care standards; b) clinical and treatment variables of bone metastatic BTcP…
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lopez-Muniz, JIC, Merino, LD, Gregori, JG, Duenas, EM, Oliveira, M, Palmer, MAS, Lopez, IA, Novoa, SA, Ezquerra, MB, Cobo, SLT
Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a…
Modelling the probability of erroneous negative lymph node staging in patients with colon cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Fortea-Sanchis, C, Forcadell-Comes, E, Martinez-Ramos, D, Escrig-Sos, J
Background: Patients in who with insufficient number of analysed lymph nodes (LNs) are more likely to receive an incorrect LN staging. The ability to calculate the overall probability of undiagnosed LN involvement errors in these patients could be very useful for approximating the real patient prognosis and for giving possible indications for adjuvant treatments. The objective of this work was to establish the predictive capacity and prognostic discriminative ability of the final error…
SEOM clinical guidelines on nutrition in cancer patients (2018)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
de las Penas, R, Majem, M, Perez-Altozano, J, Virizuela, JA, Cancer, E, Diz, P, Donnay, O, Hurtado, A, Jimenez-Fonseca, P, Ocon, MJ
Nutritional deficiency is a common medical problem that affects 15-40% of cancer patients. It negatively impacts their quality of life and can compromise treatment completion. Oncological therapies, such as surgery, radiation therapy, and drug therapies are improving survival rates. However, all these treatments can play a role in the development of malnutrition and/or metabolic alterations in cancer patients, induced by the tumor or by its treatment. Nutritional assessment of cancer patients…
Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Alarcon, MDL, Estevez, FV, Cabezon-Gutierrez, L, Padros, MC, Martin-Arroyo, JMT, Rebollo, MA, Jimenez-Lopez, AJ, Sanz-Yague, A
Objectives: We aimed to generate expert-based recommendations on the management of breakthrough cancer pain (BTcP) in older patients with cancer.
Material and Methods: A two-round multidisciplinary Delphi study. Specialists rated their agreement with a set of statements using a nine-point Likert scale (one = totally disagree and nine = totally agree). Statements were classified as appropriate (median ranged from seven to nine), irrelevant (median ranged from four to six) or inappropriate…
SEOM clinical guidelines on cardiovascular toxicity (2018)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Virizuela, JA, Garcia, AM, de las Penas, R, Santaballa, A, Andres, R, Beato, C, de la Cruz, S, Gavila, J, Gonzalez-Santiago, S, Fernandez, TL
One of the most common side effects of cancer treatment is cardiovascular disease, which substantially impacts long-term survivor's prognosis. Cardiotoxicity can be related with either a direct side effect of antitumor therapies or an accelerated development of cardiovascular diseases in the presence of preexisting risk factors. Even though it is widely recognized as an alarming clinical problem, scientific evidence is scarce in the management of these complications in cancer patients.…
Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Liu, ZB, Ezzedine, NE, Eterovic, AK, Ensor, JE, Huang, HJ, Albanell, J, Choi, DS, Lluch, A, Liu, Y, Rojo, F, Wong, H, Martinez-Duenas, E, Guerrero-Zotano, A, Shao, ZM, Darcourt, JG, Mills, GB, Dave, B, Chang, JC
Purpose Limited knowledge exists on the detection of breast cancer stem cell (BCSC)-related mutations in circulating free DNA (cfDNA) from patients with advanced cancers. Identification of new cancer biomarkers may allow for earlier detection of disease progression and treatment strategy modifications. Methods We conducted a prospective study to determine the feasibility and prognostic utility of droplet digital polymerase chain reaction (ddPCR)-based BCSC gene mutation analysis of cfDNA in…
Meaning in life moderates hopelessness, suicide ideation, and borderline psychopathology in participants with eating disorders: A longitudinal study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Marco, JH, Canabate, M, Llorca, G, Perez, S
Participants with eating disorders (EDs) experience identity problems, hopelessness, and suicide ideation. Research has confirmed the link between the experience of low meaning in life (MIL) and psychopathology. However, there is a lack of research focusing on MIL in ED. Objectives The objectives of this study are as follows: (a) to analyze whether MIL at baseline moderates the association between ED psychopathology at baseline and borderline symptoms, hopelessness, and suicide ideation at…
Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lluch, A, Gonzalez-Angulo, AM, Casadevall, D, Eterovic, AK, de Duenas, EM, Zheng, XF, Guerrero-Zotano, A, Liu, SY, Perez, R, Chen, K, Chacon, JI, Mills, GB, Antolin, S, Blancas, I, Lopez-Serra, P, Carrasco, E, Caballero, R, Prat, A, Rojo, F, Gonzalez-Perez, A, Meric-Bernstam, F, Albanell, J
Background: Changes in the clinical subtype (CS) and intrinsic subtype (IS) between breast cancer (BC) metastases and corresponding primary tumours have been reported. However, their relationship with tumour genomic changes remains poorly characterised. Here, we analysed the association between genomic remodelling and subtype conversion in paired primary and metastatic BC samples.
Methods: A total of 57 paired primary and metastatic tumours from GEICAM/2009-03 (ConvertHER, NCT01377363) study…
The effectiveness of a brief motivational nursing intervention to reduce psychoactive substance consumption in entertainment-sector workers: A transversal, observation, and semi-experimental study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Almod?var-Fernandez, I, S?nchez-Thevenet, P, Benito, A, Baquero, A, Mar?-Sanmillan, MII, Haro, G
Checking whether changes in the perception of the quality of life related to health, after the nursing intervention, influence these patients' motivation to change. This was a two-staged study undertaken in entertainment-sector workers in Spain: the first part was transversal and observational, and the second was semi-experimental. First part undertook in 284 entertainment-sector workers, selected by non-probabilistic sampling, while second part undertook in 50 entertainment-business…
Patient-Reported Outcomes-Secondary Analysis of the SCORE-2 Trial Comparing 4 Gy x 5 to 3 Gy x 10 for Metastatic Epidural Spinal Cord Compression
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Rades, D, Segedin, B, Conde-Moreno, AJ, Ferrer-Albiach, C, Metz, M, Polat, B, Badakhshi, H, Schreiber, A, Nitsche, M, Cacicedo, J, Schild, SE
Purpose: To compare 4 Gy x 5 (1 week) to 3 Gy x 10 (2 weeks) in relieving pain and distress in patients with metastatic epidural spinal cord compression (MESCC).
Methods and Materials: The randomized SCORE-2 trial compared 4 Gy x 5 (n = 101) to 3 Gy x 10 (n = 102) for MESCC. In this additional analysis, these regimens were compared for their effect in relieving pain and distress. Distress was evaluated with the distress-thermometer (0 = no distress, 10 = extreme distress) and pain on a linear…
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Bernardo-Castineira, C, Valdes, N, Celada, L, Martinez, ASJ, Saenz-de-Santa-Maria, I, Bayon, GF, Fernandez, AF, Sierra, MI, Fraga, MF, Astudillo, A, Jimenez-Fonseca, P, Ria, JC, Hevia, MA, Turienzo, E, Bernardo, C, Forga, L, Tena, I, Molina-Garrido, MJ, Cacho, L, Villabona, C, Serrano, T, Scola, B, Chirivella, I, del Olmo, M, Menendez, CL, Navarro, E, Tous, M, Vallejo, A, Athimulam, S, Bancos, I, Suarez, C, Chiara, MD
Context: SDHB mutations are found in an increasing number of neoplasms, most notably in paragangliomas and pheochromocytomas (PPGLs). SDHB-PPGLs are slow-growing tumors, but similar to 50% of them may develop metastasis. The molecular basis of metastasis in these tumors is a long-standing and unresolved problem. Thus, a better understanding of the biology of metastasis is needed.
Objective: This study aimed to identify gene methylation changes relevant for metastatic SDHB-PPGLs.
Design: We…
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Jara-Palomares, L, Alfonso, M, Maestre, A, Jimenez, D, Garcia-Bragado, F, Font, C, Reyes, RL, Blasco, LH, Vidal, G, Otero, R, Monreal, M, Adarraga, MD, Aibar, MA, Aibar, J, Amado, C, Arcelus, JI, Ballaz, A, Barba, R, Barron, M, Barron-Andres, B, Bascunana, J, Blanco-Molina, A, Camon, AM, Canas, I, Carrasco, C, Castro, J, de Ancos, C, Del Toro, J, Demelo, P, Diaz-Peromingo, JA, Diaz-Simon, R, Falga, C, Farfan, AI, Fernandez-Capitan, C, Fernandez-Criado, MD, Fernandez-Nunez, S, Fidalgo, A, Font, L, Garcia, MA, Garcia-Morillo, M, Garcia-Raso, A, Gavin-Sebastian, O, Gayol, MD, Gil-Diaz, A, Gomez, V, Gomez-Cuervo, C, Gonzalez-Martinez, J, Grau, E, Gutierrez, J, Gutierrez-Gonzalez, S, Iglesias, M, Jaras, MJ, Jou, I, Joya, MD, Lalueza, A, Lima, J, Llamas, P, Lobo, JL, Lopez-Jimenez, L, Lopez-Miguel, P, Lopez-Nunez, JJ, Lopez-Saez, JB, Lorente, MA, Lorenzo, A, Loring, M, Madridano, O, Marchena, PJ, Martin, JM, Mellado, M, Morales, MD, Nieto, ML, Nieto, JA, Nunez, MJ, Olivares, MC, Pedrajas, JM, Pellejero, G, Prez-Rus, G, Peris, ML, Porras, JA, Rivas, A, Rodriguez-Davila, MA, Rodriguez-Hernandez, AA, Rubio, CM, Ruiz-Artacho, P, Ruiz-Ruiz, J, Ruiz-Sada, P, Sahuquillo, JC, Salazar, V, Samperiz, A, Munoz-Torrero, JFS, Sancho, T, Soler, S, Surinach, JM, Tapia, E, Tolosa, C, Torres, MI, Trujillo-Santos, J, Uresandi, F, Valle, R, Villares, P, Gutierrez, P, Vazquez, FJ, Vilaseca, A, Vanassche, T, Vandenbriele, C, Verhamme, P, Hirmerova, J, Maly, R, Celis, G, del Pozo, G, Salgado, E, Benzidia, I, Bertoletti, L, Bura-Riviere, A, Debourdeau, P, Farge-Bancel, D, Hij, A, Mahe, I, Moustafa, F, Schellong, S, Braester, A, Brenner, B, Tzoran, I, Sharif-Kashani, B, Barillari, G, Bilora, F, Bortoluzzi, C, Brandolin, B, Bucherini, E, Ciammaichella, M, Dentali, F, Di Micco, P, Maida, R, Mastroiacovo, D, Mumoli, N, Pace, F, Parisi, R, Pesavento, R, Prandoni, P, Quintavalla, R, Rocci, A, Romualdi, R, Sinicalchi, C, Tufano, A, Visona, A, Hong, NV, Zalunardo, B, Gibietis, V, Kigitovica, D, Skride, A, Bosevski, M, Bounameaux, H, Mazzolai, L, Caprini, JA, Bui, HM, Pham, KQ, Reis, A, RIETE Investigators
In young patients with acute pulmonary embolism (PE), the predictive value of currently available prognostic tools has not been evaluated. Our objective was to compare prognostic value of 7 available tools (GPS, PESI, sPESI, Prognostic Algorithm, PREP, shock index and RIETE) in patients aged <50 years. We used the RIETE database, including PE patients from 2001 to 2017. The major outcome was 30-day all-cause mortality. Of 34,651 patients with acute PE, 5,822 (17%) were aged <50 years. Of…
Are there enough radiation oncologists to lead the new Spanish radiotherapy?
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Rodriguez, A, Arenas, M, Lara, PC, Lopez-Torrecilla, J, Algara, M, Conde, A, Perez-Montero, H, Munoz, JL, Peleteiro, P, Perez-Calatayud, MJ, Contreras, J, Ferrer, C, Ortiz, MJ, Exposito, J, Palacios, A, Herruzo, I, Medina, JA, Martinez, M, Bayo, E, Jaen, J, Peracaula, FJ, Perez, C, Ramos, MI, Gonzalez, JA, Begara, J, Nuno, C, Bezares, AB, Serradilla, A, Lazo, A, Tejedor, M, Mendez, L, Juan, G, Olay, L, Pardo, J, Noe, A, Mestre, F, Oton, C, Fuentes, C, Prada, P, Perez, L, Lozano, E, Villas, MV, Tripero, J, Lobo, R, Munoz, M, Tisaire, JL, Fernandez, J, Teijeira, M, Rodriguez, JR, Perez-Romasanta, L, Lopez, F, Rodriguez, D, Ceballos, A, Cantalapiedra, R, Biete, A, Craven, J, Pedro, A, Giralt, J, Guedea, F, Villa, S, Sole, JM, Eraso, A, Carceller, JA, Guix, B, Miralbell, R, Casals, J, Gonzalez, P, Duarte, MI, Jerez, JP, Marino, A, Gomez-Caamano, A, Munoz, V, Lopez, MD, Zugazabeitia, L, Torrado-Moya, L, Ossola, G, Morera, RM, Murillo, MT, Sancho, S, Perez-Regadera, J, Lozano, MA, Vazquez, G, Lopez, E, de la Fuente, C, Samper, P, Ludena, B, Saez, JDD, Azinovic, I, Rubio, C, del Cerro, E, Carballo, N, Sotoca-Ruiz, A, Garcia, R, Salinas, J, Fondevilla, A, Martinez-Monge, R, Martinez, E, Alia, A, Ciria, JP, Rosa, J, Bilbao, P, Martin, JC, Casquero, F, Arribas, L, Tormo, A, Ferrer, E, Larrea, L, Soler, M, Garcia, E, Soler, P, Santos, M, Vazquez, G, Canon, RM, Miro, A, Spanish Soc Oncology Radiotherapy
Aim Radiation oncology services in Spain are undergoing a process of technical modernization, but-in a context of increasing demand by an ageing population-it is unclear whether there are enough radiation oncologists to staff the newly equipped units. This study aims to assess the number of specialists working in radiation oncology services in Spain relative to current and future needs. Materials and methods In the second half of 2017, the Commission on Infrastructures of the Spanish Society…
Current management of breakthrough cancer pain according to physicians from pain units in Spain
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Estevez, FV, Alarcon, MDL, Mayoral, V, de Madariaga, M, Margarit, C, Duran, JA, Martin-Arroyo, JMT, Carregal, A, SED
PurposeCurrent evidence suggests the need to improve the management of breakthrough cancer pain (BTcP). For this reason, we aimed to assess the opinion of a panel of experts composed exclusively of physicians from pain units, who play a major role in BTcP diagnosis and treatment, regarding the key aspects of BTcP management.MethodsAn ad hoc questionnaire was developed to collect real-world data on the management of BTcP. The questionnaire had 5 parts: (a) organizational aspects of pain units (n…
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Alvarez-Torres, MD, Juan-Albarracin, J, Fuster-Garcia, E, Bellvis-Bataller, F, Lorente, D, Reynes, G, de Mora, JF, Aparici-Robles, F, Botella, C, Munoz-Langa, J, Faubel, R, Asensio-Cuesta, S, Garcia-Ferrando, GA, Chelebian, E, Auger, C, Pineda, J, Rovira, A, Oleaga, L, Molla-Olmos, E, Revert, AJ, Tshibanda, L, Crisi, G, Emblem, KE, Martin, D, Due-Tonnessen, P, Meling, TR, Filice, S, Saez, C, Garcia-Gomez, JM
Background Glioblastoma (GBM) is the most aggressive primary brain tumor, characterized by a heterogeneous and abnormal vascularity. Subtypes of vascular habitats within the tumor and edema can be distinguished: high angiogenic tumor (HAT), low angiogenic tumor (LAT), infiltrated peripheral edema (IPE), and vasogenic peripheral edema (VPE). Purpose To validate the association between hemodynamic markers from vascular habitats and overall survival (OS) in glioblastoma patients, considering the…
Sociodemographic, Clinical, and Therapeutic Aspects of Penitentiary Psychiatric Consultation: Toward Integration Into the General Mental Health Services
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Arnau, F, Garcia-Guerrero, J, Benito, A, Vera-Remartinez, EJ, Baquero, A, Haro, G
The characteristics of mental disorders, as well as deficiencies in their treatment, must be properly defined. This was a prospective, longitudinal, observational study, in which all men referred to a penitentiary psychiatric consultation of three penitentiary centers in Spain were invited to participate. Those who consented to participation (1328) were interviewed at the baseline timepoint and at intervals for up to 3 years. The presence of mental disorders was high: 68.2% had a cluster B…
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Estival, A, Sanz, C, Ramirez, JL, Velarde, JM, Domenech, M, Carrato, C, de las Penas, R, Gil-Gil, M, Sepulveda, J, Armengol, R, Cardiel, I, Berrocal, A, Luque, R, Herrero, A, Balana, C
Circulating biomarkers in blood may provide an interesting alternative to risky tissue biopsies in the diagnosis and follow-up of glioblastoma patients. We have assessed MGMT methylation status in blood and tissue samples from unresected glioblastoma patients who had been included in the randomized GENOM-009 trial. Paired blood and tissue samples were assessed by methylation-specific PCR (MSP) and pyrosequencing (PYR). After establishing the minimum PYR cut-off that could yield a significant…
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Isla, D, de las Penas, R, Insa, A, Marse, R, Martinez-Banaclocha, N, Mut, P, Moran, T, Sala, MA, Massuti, B, Ortega, AL, Jurado, JM, Gomez-Codina, J, Diz, P, Artal, A, Gutierrez, V, Vazquez, MF, Vinolas, N, Maestu, I, Camps, C, Alvarez, R, Soto, MAD, Ponce, S, Provencio, M
Objectives: Concomitant chemo-radiation is the standard treatment for unresectable stage III non-small cell lung cancer (LA-NSCLC), The aim of this study was to assess the safety and efficacy of oral vinorelbine and cisplatin (OVP) compared with etoposide and cisplatin (EP), both in combination with radiotherapy, in this setting.
Material and methods: An open-label, randomized phase II trial was undertaken including 23 hospitals in Spain. Adults with untreated unresectable stage III NSCLC were…
Sensorimotor Gating in Cocaine-Related Disorder with Comorbid Schizophrenia or Antisocial Personality Disorder
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Fuertes-Saiz, A, Benito, A, Mateu, C, Carratala, S, Almodovar, I, Baquero, A, Haro, G
Objective: Schizophrenia, cocaine-related disorder, antisocial personality disorder, and psychopathy share biological bases, but few studies discriminate between these disorders by means of prepulse inhibition. This work studies the phenotype of patients with cocaine-related disorders who are vulnerable to presenting a dual diagnosis of schizophrenia or antisocial personality disorder, by evaluating their prepulse inhibition, impulsivity and psychopathy personality traits. Methods: The sample…
Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Ferrero, VT, Oset, MM, Masferrer, JP, Pardo, EH, Sorolla, EJ, Largo, SC, Tormo, V, Marcos, M, Pardo, J, Aymar, N, Hortelano, E, Flaquer, A, Jorda, E, Cordoba, S, Corona, JA, Ferrer, C, Frances, A, Morillo, V, Bouche, A, Marin, S, Cambray, M, Ventura, M, Perez, H, Hernandez, R, Martin, JJ, Lorenzo, L, Fuentes, C, Zurita, M, del Moral, R, Munoz, V, Gonzalez, A, Enguix, M, Martinez, M, Ortiz, MJ, Fernandez, MC, Cardenas, E, Lozano, AJ
Purpose Radiotherapy-induced dysfunction of the gastrointestinal tract is common in cancer patients and has a significant impact on their quality of life. In this study, we investigated the prevalence of breakthrough cancer pain (BTcP) in patients undergoing 3D pelvic radiotherapy and who had proctalgia. Methods This observational, multicenter, cross-sectional epidemiological study was performed in 13 Spanish hospitals. Data were obtained on the presence and characteristics of BTcP,…
SEOR recommendations on the use of protons.
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lloret-Saez-Bravo, M, Giralt-L de Sagredo, J, Contreras-Martinez, J, Ferrer-Albiach, C
Clinical validation of risk scoring systems to predict risk of delayed bleeding after EMR of large colorectal lesions
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Albeniz, Eduardo, Zebenzuy Gimeno-Garcia, Antonio, Fraile, Maria, Ibanez, Berta, Guarner-Argente, Carlos, Alonso-Aguirre, Pedro, Antonio Alvarez, Marco, Jerusalen Gargallo, Carla, Pellise, Maria, Ramos Zabala, Felipe, Herreros de Tejada, Alberto, Nogales, Oscar, Martinez-Ares, David, Mugica, Fernando, de la Pena, Joaquin, Espinos, Jorge, Huerta, Alain, Alvarez, Alberto, Gonzalez-Santiago, Jesus M., Navajas, Francisco, Gabriel Martinez-Cara, Juan, Redondo-Cerezo, Eduardo, Merlo Mas, Josep, Sabado, Fernando, Rivero, Liseth, Saperas, Esteban, Soto, Santiago, Rodriguez-Sanchez, Joaquin, Lopez-Roses, Leopoldo, Rodriguez-Tellez, Manuel, Rullan Iriarte, Maria, Elosua Gonzalez, Alfonso, Pardeiro, Remedios, Valdivielso Cortazar, Eduardo, Concepcion-Martin, Mar, Huelin Alvarez, Patricia, Colan Hernandez, Juan, Cobian, Julyssa, Santiago, Jose, Jimenez, Alejandra, Remedios, David, Lopez-Viedma, Bartolome, Garcia, Orlando, Martinez-Alcala, Felipe, Perez-Roldan, Francisco, Carbo, Jorge, Enguita, Monica
Background and Aims: The Endoscopic Resection Group of the Spanish Society of Endoscopy (GSEED-RE) model and the Australian Colonic Endoscopic Resection (ACER) model were proposed to predict delayed bleeding (DB) after EMR of large superficial colorectal lesions, but neither has been validated. We validated and updated these models.
Methods: A multicenter cohort study was performed in patients with nonpedunculated lesions >= 20 mm removed by EMR. We assessed the discrimination and…
Replied to "Some remarks to SEOM clinical guidelines on cardiovascular toxicity (2018)"
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Virizuela, J. A., Martin Garcia, A., de las Penas, R., Santaballa, A., Andres, R., Beato, C., de la Cruz, S., Gavila, J., Gonzalez-Santiago, S., Lopez Fernandez, T.
Patient safety in radiation oncology in Spain: a need to change
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Pardo Masferrer, J., del Cerro Penalver, E., Contreras Martinez, J., Ferrer Albiach, C., Spanish Soc Radiation Oncology SEO
Purpose The Working Group on Patient Safety and Quality of the Spanish Society of Radiation Oncology, revised the most relevant national and international recommendations, selecting a series of important aspects for patient safety, evaluating whether they are included in Spanish legislation Materials and methods We have considered a concept as relevant to the patient safety in radiotherapy if so defined in at least 8 of the 16 documents reviewed. Results 12 subjects were selected: training and…
Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Sanchez-Heras, AB, Castillejo, A, Garcia-Diaz, JD, Robledo, M, Teule, A, Sanchez, R, Zuniga, A, Lastra, E, Duran, M, Llort, G, Yague, C, Cajal, TRY, San Martin, CL, Lopez-Fernandez, A, Balmana, J, Robles, L, Mesa-Latorre, JM, Chirivella, I, Fonfria, M, Ibanez, RP, Castillejo, MI, Escandell, I, Gomez, L, Berbel, P, Soto, JL
Simple Summary
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is a very rare hereditary disorder characterized by cutaneous leiomyomas (CLMs), uterine leiomyomas (ULMs), renal cysts (RCys) and renal cell cancer (RCC), with no data on its prevalence worldwide. No genotype-phenotype associations have been described. The aim of our study was to describe the genotypic and phenotypic features of the largest series of patients with HLRCC from Spain reported to date. Of 27 FH…
Adherence to the Sociedad Espanola de Oncologia Medica (SEOM) Algorithm for the Treatment of Hyponatremia in Oncology Patients in Spain: The ALGA Study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Henao, F, Manzano, A, Lopez, RL, Gobartt, AL, de las Penas, R
Plain Language Summary Low levels of sodium in the blood occur in almost half of patients with cancer who are hospitalized. In some patients, this may be fatal. A care pathway was developed by the Sociedad Espanola de Oncologia Medica in 2014 to support doctors in providing the best care for these patients. Clinical records for 70 patients with cancer at four Spanish hospitals were reviewed to determine whether treatment was given according to the care pathway. Less than one-third of patients…
A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Balana, C, Vaz, MA, Sepulveda, JM, Mesia, C, del Barco, S, Pineda, E, Munoz-Langa, J, Estival, A, de las Penas, R, Fuster, J, Girones, R, Navarro, LM, Gil-Gil, M, Alonso, M, Herrero, A, Peralta, S, Olier, C, Perez-Segura, P, Covela, M, Martinez-Garcia, M, Berrocal, A, Gallego, O, Luque, R, Perez-Martin, FJ, Esteve, A, Munne, N, Domenech, M, Villa, S, Sanz, C, Carrato, C
Background. Standard treatment for glioblastoma is radiation with concomitant and adjuvant temozolomide for 6 cycles, although the optimal number of cycles of adjuvant temozolomide has long been a subject of debate. We performed a phase II randomized trial investigating whether extending adjuvant temozolomide for more than 6 cycles improved outcome.
Methods. Glioblastoma patients treated at 20 Spanish hospitals who had not progressed after 6 cycles of adjuvant temozolomide were centrally…
Patterns of practice for adaptive and real-time radiation therapy (POP-ART RT) part II: Offline and online plan adaption for interfractional changes
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Bertholet, J, Anastasi, G, Noble, D, Bel, A, van Leeuwen, R, Roggen, T, Duchateau, M, Pilskog, S, Garibaldi, C, Tilly, N, Garcia-Molla, R, Bonaque, J, Oelfke, U, Aznar, MC, Ben Heijmen
Purpose: The POP-ART RT study aims to determine to what extent and how intrafractional real-time respiratory motion management (RRMM), and plan adaptation for interfractional anatomical changes (ART) are used in clinical practice and to understand barriers to implementation. Here we report on part II: ART using more than one plan per target per treatment course.
Materials and methods: A questionnaire on the current practice of ART, wishes for expansion or implementation, and barriers to…
Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Ciruelos, E, Villagrasa, P, Pascual, T, Oliveira, M, Pernas, S, Pare, L, Escriva-de-Romani, S, Manso, L, Adamo, B, Martinez, E, Cortes, J, Vazquez, S, Perello, A, Garau, I, Mele, M, Martinez, N, Montano, A, Bermejo, B, Morales, S, Echarri, MJ, Vega, E, Gonzalez-Farre, B, Martinez, D, Galvan, P, Canes, J, Nuciforo, P, Gonzalez, X, Prat, A
Purpose: To assess palbociclib in combination with trastuzumab with or without endocrine therapy in patients with HER2-positive advanced breast cancer.
Patients and Methods: PATRICIA is a prospective, open-label, multicenter phase II trial. Patients had received 2-4 prior lines of anti-HER2-based regimens. Treatment consisted of palbociclib 200 mg daily for 2 weeks and 1 week off plus trastuzumab. The study was based on a Simon two-stage design comprising three cohorts: estrogen receptor (ER)…
Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Sepulveda-Sanchez, JM, Gil-Gil, M, Alonso-Garcia, M, Salgado, MAV, Vicente, E, Barroso, CM, Sanchez, AR, Duran, G, de las Penas, R, Munoz-Langa, J, Velasco, G, Hernandez-Lain, A, Hilario, A, Martin, MN, Benavides, M, Oleaga, L, Montenegro, DC, Ruano, Y, Sanchez-Gomez, P, Martin-Soberon, MC, Morales-Llombart, R, Pachon, V, Pineda, E
Background The cell cycle checkpoint G1/S, dependent on cyclin-dependent kinase (CDK) 4 amplification/overexpression and retinoblastoma phosphorylation, is altered in most anaplastic oligodendrogliomas (AOs). Objective We aimed to evaluate the efficacy of palbociclib, an oral inhibitor of CDK4/6 with proven efficacy in breast cancer, in patients with AO. The primary endpoint was progression-free survival at 6 months. Patients and Methods We conducted a multicenter, open-label, phase II trial…
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Garcia-Recio, S, Thennavan, A, East, MP, Parker, JS, Cejalvo, JM, Garay, JP, Hollern, DP, He, XP, Mott, KR, Galvan, P, Fan, C, Selitsky, SR, Coffey, AR, Marron, D, Braso-Maristany, F, Burgues, O, Albanell, J, Rojo, F, Lluch, A, de Duenas, EM, Rosen, JM, Johnson, GL, Carey, LA, Prat, A, Perou, CM
Mechanisms driving tumor progression from less aggressive subtypes to more aggressive states represent key targets for therapy. We identified a subset of luminal A primary breast tumors that give rise to HER2-enriched (HER2E) subtype metastases, but remain clinically HER2 negative (cHER2). By testing the unique genetic and transcriptomic features of these cases, we developed the hypothesis that FGFR4 likely participates in this subtype switching. To evaluate this, we developed 2 FGFR4 genomic…
Caring for older patients with cancer during the COVID-19 pandemic: A Young International Society of Geriatric Oncology (SIOG) global perspective
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Desideri, I, Pilleron, S, Battisti, NML, Gomes, F, de Glas, N, Neuendorff, NR, Liposits, G, Paredero-Perez, I, Lok, WCW, Loh, KP, DuMontier, C, Mian, H, Soto-Perez-de-Celis, E
The ongoing coronavirus disease 2019 (COVID-19) pandemic has affected millions of people in over 180 territories, causing a significant impact on healthcare systems globally. Older adults, as well as people living with cancer, appear to be particularly vulnerable to COVID-19 related morbidity and mortality, which means that older adults with cancer are an especially high-risk population. This has led to significant changes in the way geriatric oncologists provide care to older patients,…
Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Estevez, FV, Alarcon, MDL, Babarro, AA, Gayoso, LO, de Castro, J, Leria-Gelabert, M, Melogno-Klinkas, M
Objectives:Multiple reasons for suboptimal treatment of breakthrough cancer pain (BTcP) have been reported in the literature. We aimed to ascertain the perception of physicians on the potential inappropriate use and prescription of rapid-onset opioids (ROOs) for breakthrough cancer pain (BTcP) and the causes thereof. Methods:Observational study based on an online survey addressed to doctors from different specialties (radiation oncology, medical oncology, anesthesia, palliative care and general…
Intraoperative radiation therapy (IORT) for soft tissue sarcoma - ESTRO IORT Task Force/ACROP recommendations
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Roeder, F, Morillo, V, Saleh-Ebrahimi, L, Calvo, FA, Poortmans, P, Albiach, CF
Purpose: To describe guidelines for the use of intraoperative radiation therapy (IORT) in the treatment of soft-tissue sarcomas (STS).
Methods: A panel of experts in the field performed a systematic literature review, supplemented their clinical experience and developed recommendations for the use of IORT in the treatment of STS.
Results: Based on the evidence from the systematic literature review and the clinical experience of the panel members, recommendations regarding patient selection,…
Urodynamic Differences between Complete and Incomplete Spinal Cord Injuries with Neurogenic Detrusor Overactivity
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Fadrique, GG, Gallego, D, Ordaz, G, Climent, L
Objective: To analyze if there are urodynamic differences in patients with neurogenic detrusor overactivity (NDO) secondary to spinal cord injury (SCI) depending on whether the SCI is complete or incomplete according to the American Spinal Injury Association (ASIA) classification. Methods: A retrospective and comparative study was carried out, including 194 patients with suprasacral SCI and NDO. Maximum cystometric capacity (MCC), volume at first involuntary contraction (VIC), compliance,…
Multidisciplinary management of liver metastases in patients with colorectal cancer: a consensus of SEOM, AEC, SEOR, SERVEI, and SEMNIM
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Vera, R, Gonzalez-Flores, E, Rubio, C, Urbano, J, Camps, MV, Ciampi-Dopazo, JJ, Rincon, JO, Macias, VM, Braco, MAG, Suarez-Artacho, G
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by cancer. Nearly 20% of patients with CRC will have metastases at the time of diagnosis, and more than 50% of patients with CRC develop metastatic disease during the course of their disease. A group of experts from the Spanish Society of Medical Oncology, the Spanish Association of Surgeons, the Spanish Society of Radiation Oncology, the Spanish Society of Vascular and Interventional Radiology, and…
Implementation of a positive psychology group program in an inpatient eating disorders service: a pilot study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Enrique, A, Breton-Lopez, J, Molinari, G, Llorca, G, Botella, C
Context Eating disorders (ED) are very difficult conditions to treat. Therefore, interventions in this field are shifting their main target towards the disorder's impact in quality of life, rather than ED symptomatology in itself. In this sense, a focus in the promotion of positive emotions and well-being is emerging to ameliorate the harmful effects caused by ED. However, evidence of the potential benefits of this type of interventions is still scarce. Purpose This study introduces a 4…
Clinical activity of a htert (vx-001) cancer vaccine as post-chemotherapy maintenance immunotherapy in patients with stage IV non-small cell lung cancer: final results of a randomised phase 2 clinical trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Gridelli, C, Ciuleanu, T, Domine, M, Szczesna, A, Bover, I, Cobo, M, Kentepozidis, N, Zarogoulidis, K, Kalofonos, C, Kazarnowisz, A, Korozan, M, de las Penas, R, Majem, M, Chella, A, Griesinger, F, Bournakis, E, Sadjadian, P, Kotsakis, A, Chinet, T, Syrigos, KN, Correale, P, Gallou, C, Jamet, JM, Vetsika, EK, Kosmatopoulos, K, Georgoulias, V, Vx 001 201 Trial Team
Background The cancer vaccine Vx-001, which targets the universal tumour antigen TElomerase Reverse Transcriptase (TERT), can mount specific Vx-001/TERT572 CD8 + cytotoxic T cells; this immune response is associated with improved overall survival (OS) in patients with advanced/metastatic non-small cell lung cancer (NSCLC). Methods A randomised, double blind, phase 2b trial, in HLA-A*201-positive patients with metastatic, TERT-expressing NSCLC, who did not progress after first-line platinum…
Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (CRPC): a post hoc analysis of two randomized clinical trials
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Carretero-Gonzalez, A, Lora, D, Manneh, R, Lorente, D, Castellano, D, de Velasco, G
In castration-resistant prostate cancer (CRPC) patients, observational studies have reported that statins may boost the antitumor activity of abiraterone (AA) and data suggest an improvement in efficacy; conclusions with vitamin D are less clear but an eventual benefit has been pointed. We conducted a post hoc analysis of individual patient data of CRPC patients treated with prednisone and/or AA with or without statins/vitamin D on randomized clinical trials. In the COU-AA-301 trial, use of AA…
Risk-taking and fairness among cocaine-dependent patients in dual diagnoses: Schizophrenia and Anti-Social Personality Disorder
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Sabater-Grande, G, Haro, G, Garcia-Gallego, A, Georgantzis, N, Herranz-Zarzoso, N, Baquero, A
This study reports experimental results from a clinical sample of patients with a cocaine-related disorder and dual diagnosis: Schizophrenia and Anti-Social Personality Disorder. Both types of patients as well as a non-clinical group of students performed two incentivized decision-making tasks. In the first part of the experiment, they performed a lottery-choice task in order to elicit their degree of risk aversion. In the second part, they decided in two modified dictator games aimed at…
Safety in radiation oncology: transposition of directive 2013/59/EURATOM in the Spanish Radiation Oncology Departments-recommendations for its adequate and effective application
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Masferrer, JP, Martin, CP, Albiach, CF
Introduction The Official Journal of the European Union published on January 17, 2014 the Council Directive 2013/59/EURATOM of December 5, 2013, which establishes basic safety standards for the protection against the dangers derived from the exposure to ionizing radiation, and should have been transposed to the regulations of the member countries of the European Union. Methods We carried out and exhaustive review of the Directive, to highlight its aspects referred to radiotherapy, in order to…
Nutritional impact of radiotherapy in oncogeriatric patients. Can radiation oncologists minimize the radiotherapy impact on the nutritional status of the elderly patient?
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Soria, RM
Cancer in elderly patients represents a global health challenge due to the increase in its incidence and its associated mortality. In our country it is the second leading cause of death in people over 65 years. In the coming years, the problem will increase, with a prognosis of people over 65 years of 35% in 2050. Radiotherapy is an essential part of the multidisciplinary treatment of cancer in elderly patients, where sometimes it is considered as the first therapeutic option and others, as an…
Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Jose, JFM, Jose, M, Silverio, R, Federico, V, Isabel, C, Martin, OA, Inmaculada, B, Cristina, C, Julia, HC, Dolores, TM, Jose, G, Paola, P, Nieves, D, Vicent, A, Sara, B, Sara, M, Julian, L, Manuel, S, del Carmen, MM, Angel, CM, Vicente, G
Background (or purpose) Nivolumab has been shown to be effective for the treatment of second-line mRCC. The present study has investigated the effectiveness and safety of nivolumab in real-world Eastern Spanish patients with advanced mRCC at TKI progression. Patients and methods A retrospective review of mRCC patients treated with nivolumab as a second-line treatment was performed. Analyzed variables included age, sex, ECOG (quality of life scale designed by the Eastern Cooperative Oncology…
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Braso-Maristany, F, Griguolo, G, Pascual, T, Pare, L, Nuciforo, P, Llombart-Cussac, A, Bermejo, B, Oliveira, M, Morales, S, Martinez, N, Vidal, M, Adamo, B, Martinez, O, Pernas, S, Lopez, R, Munoz, M, Chic, N, Galvan, P, Garau, I, Manso, L, Alarcon, J, Martinez, E, Gregorio, S, Gomis, RR, Villagrasa, P, Cortes, J, Ciruelos, E, Prat, A
The HER2-enriched (HER2-E) subtype within HER2-positive (HER2+) breast cancer is highly addicted to the HER2 pathway. However, similar to 20-60% of HER2+/HER2-E tumors do not achieve a complete response following anti-HER2 therapies. Here we evaluate gene expression data before, during and after neoadjuvant treatment with lapatinib and trastuzumab in HER2+/HER2-E tumors of the PAMELA trial and breast cancer cell lines. Our results reveal that dual HER2 blockade in HER2-E disease induces a low…
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lluch, A, Barrios, CH, Torrecillas, L, Ruiz-Borrego, M, Bines, J, Segalla, J, Guerrero-Zotano, A, Garcia-Saenz, JA, Torres, R, de la Haba, J, Garcia-Martinez, E, Gomez, HL, Llombart, A, Bofill, JS, Baena-Canada, JM, Barnadas, A, Calvo, L, Perez-Michel, L, Ramos, M, Fernandez, I, Rodriguez-Lescure, A, Cardenas, J, Vinholes, J, de Duenas, EM, Godes, MJ, Segui, MA, Anton, A, Lopez-Alvarez, P, Moncayo, J, Amorim, G, Villar, E, Reyes, S, Sampaio, C, Cardemil, B, Escudero, MJ, Bezares, S, Carrasco, E, Martin, M, Corona, J, Jara, C, Cardemil, B, Toro, R, Pimentel, C, Hernando, B, Vicente, E, Zagame, L, Gil, M, Estevez, LG, Rodriguez, C, de la Cruz, MA, Tello, JM, Campos, S, Lomas, M, Capdevile, D, Campos, M, Margeli, M, Andres, R, Tusquets, I, Ballesteros, A, Guerrero, A, Arguello, M, Rodriguez, JL, Munoz, M, Florian, J, Azevedo, S, Mondragon, R, Peralta, J, Palomo, AE, Barajas, LJ, Arcusa, A, Carranza, H, Garcia, C, Umbria, C, Ales, JE, Vega, JML, Romeo, M, Valero, J, Alonso, JL, Mathias, C, Gutierrez, F, Adrover, E, Nunez, P, Mendiola, C, Cassinello, J, de la Huerta, A, Geicam Spanish Breast Canc Grp, CIBOMA Iberoamer Coalition Res Bre, LACOG
PURPOSE Operable triple-negative breast cancers (TNBCs) have a higher risk of relapse than non-TNBCs with standard therapy. The GEICAM/2003-11_CIBOMA/2004-01 trial explored extended adjuvant capecitabine after completion of standard chemotherapy in patients with early TNBC.
PATIENTS AND METHODS Eligible patients were those with operable, node-positive-or node negative with tumor 1 cm or greater-TNBC, with prior anthracycline- and/or taxane-containing chemotherapy. After central confirmation of…
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Prat, A, Saura, C, Pascual, T, Hernando, C, Munoz, M, Pare, L, Farre, BG, Fernandez, PL, Galvan, P, Chic, N, Farre, XG, Oliveira, M, Gil-Gil, M, Arumi, M, Ferrer, N, Montano, A, Izarzugaza, Y, Llombart-Cussac, A, Bratos, R, Santiago, SG, Martinez, E, Hoyos, S, Rojas, B, Virizuela, JA, Ortega, V, Lopez, R, Celiz, P, Ciruelos, E, Villagrasa, P, Gavila, J
Background In hormone receptor-positive, HER2-negative early stage breast cancer, cyclin-dependent kinases 4 and 6 (CDK4/6) inhibition in combination with endocrine therapy could represent an alternative to multiagent chemotherapy. We aimed to evaluate the biological and clinical activity of neoadjuvant ribociclib plus letrozole in the luminal B subtype of early stage breast cancer.
Methods CORALLEEN is a parallel-arm, multicentre, randomised, open-label, phase 2 trial completed across 21…
Rare Site Hepatocellular Carcinoma Metastasis
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Boldo, E, Santafe, A, Mayol, A, Lozoya, R, Coret, A, Escribano, D, Fortea-Sanchis, C, Munoz, A, Pastor, JC, de Lucia, GP, Bosch, N
Introduction: Besides more common sites such as lung or peritoneum, hepatocellular carcinoma (HCC) can metastatize to rare sites. We report herein a new metastatic site of HCC: the nail-bed. We also review other recently reported rare site HCC metastases (RSHM).
Case Report: A 66-year-old woman with a 12-year history of resected-stage IA HCC who later presented lung, spleen and brain metastases treated with surgery, systemic therapies (sorafenib, sunitinib, capecitabine) and radiotherapy. The…
Real-world clinical practice patterns and outcomes for advanced ovarian cancer in Spain (GEICO-42-R study)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Redondo, A, Girones, R, Ruiz, N, Iglesias, M, Mendiola, C, Santaballa, A, Manzano, A, Rubio, MJ, Mallol, P, Tornamira, MV, Jimenez, M, Gonzalez-Martin, A
Objective: To assess epidemiological, pathological and clinical characteristics, therapeutic management patterns and outcomes in the management of advanced ovarian cancer (AOC) in clinical practice. Methods: Multicenter, retrospective, epidemiological, observational real-world study reviewing clinical records from 277 patients diagnosed with AOC between January 2008 and December 2010 who were treated and followed in 31 Spanish hospitals belonging to the Spanish Ovarian Cancer Research Group…
Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lorente, D, Llacer, C, Lozano, R, de Velasco, G, Romero-Laorden, N, Rodrigo, M, Sanchez-Iglesias, A, di Capua, C, Castro, E, Ferrer, C, Sanchez-Hernandez, A, Olmos, D
Background: Most available prognostic nomograms in metastatic castration-resistant prostate cancer (mCRPC) are derived from datasets not representative of the current treatment landscape. A prognostic nomogram for first-line mCRPC treatment was developed from patients treated in the PREVAIL study.
Objective: To validate the Armstrong model in the COU-AA-302 trial.
Design, setting, and participants: A post hoc analysis of mCRPC patients treated in the COU-AA-302 trial was carried out…
Fulvestrant-Palbociclib vs Letrozole-Palbociclib as Initial Therapy for Endocrine-Sensitive, Hormone Receptor-Positive, ERBB2-Negative Advanced Breast Cancer A Randomized Clinical Trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Llombart-Cussac, A, Perez-Garcia, JM, Bellet, M, Dalenc, F, Gil-Gil, M, Ruiz-Borrego, M, Gavila, J, Sampayo-Cordero, M, Aguirre, E, Schmid, P, Marme, F, Di Cosimo, S, Gligorov, J, Schneeweiss, A, Albanell, J, Zamora, P, Wheatley, D, Martinez-de Duenas, E, Amillano, K, Malfettone, A, Cortes, J
Question Which is the optimal endocrine partner (fulvestrant vs letrozole) for cyclin-dependent kinase 4 and 6 inhibitor palbociclib in previously untreated, endocrine-sensitive, hormone receptor-positive, ERBB2-negative advanced breast cancer?
Findings In this randomized, open-label, phase 2 trial, 486 patients were assigned in equal numbers to receive palbociclib plus fulvestrant or letrozole. Median investigator-assessed progression-free survival was 27.9 months for fulvestrant-palbociclib…
Involvement of intestinal dysbiosis in the etiopathogenesis and treatment of autism spectrum disorder; a bibliographic review
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Real-Lopez, M, Peraire, M, Ramos-Vidal, C, Nath, D, Hervas, A, Cortes, X
Introduction. Autism spectrum disorder is a neurodevelopmental disorder with phenotypic heterogeneity and variable symptomatic course of partly unknown etiology. The prevalence of gastrointestinal disorders in autism leads to investigate the role that intestinal microbiota may have as a causal factor and to propose specific therapeutic interventions. The role of microbiota in brain development and function, demonstrated in animal models, justifies its investigation in this neuropsychiatric…
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Ferrarotto, R, Anderson, I, Medgyasszay, B, Garcia-Campelo, MR, Edenfield, W, Feinstein, TM, Johnson, JM, Kalmadi, S, Lammers, PE, Sanchez-Hernandez, A, Pritchett, Y, Morris, SR, Malik, RK, Csoszi, T
Background Supportive care interventions used to manage chemotherapy-induced myelosuppression (CIM), including granulocyte colony-stimulating factors (G-CSFs), erythropoiesis-stimulating agents (ESAs), and red blood cell (RBC) transfusions, are burdensome to patients and associated with greater costs to health care systems. We evaluated the utilization of supportive care interventions and their relationship with the myeloprotective agent, trilaciclib. Methods Data were pooled from three…
Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Peris, M, Lopez-Nunez, JJ, Maestre, A, Jimenez, D, Muriel, A, Bikdeli, B, Weinberg, I, Ay, C, Mazzolai, L, Lorenzo, A, Monreal, M, RIETE Investigators
Background Current guidelines suggest treating cancer patients with incidental pulmonary embolism (PE) similarly to those with clinically suspected and confirmed PE. However, the natural history of these presentations has not been thoroughly compared.
Methods We used the data from the RIETE (Registro Informatizado de Enfermedad TromboEmbolica) registry to compare the 3-month outcomes in patients with active cancer and incidental PE versus those with clinically suspected and confirmed PE. The…
Procedural pain in patients with cancer: a Delphi expert management consensus
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Estevez, FJV, Alarcon, MDL, Beato, C, Sanz-Yague, A, Porta-Sales, J, Lopez, RMM
Objectives Diagnosis, treatment and care of cancer often involve procedures that may be distressing and potentially painful for patients. The PROCEDIO Study aimed to generate expert-based recommendations on the management of moderate to severe procedural pain in inpatients and outpatients with cancer. Methods Using a two-round Delphi method, experts from pain and palliative care units, medical and radiation oncology and haematology departments expressed their agreement on 24 statements using a…
Characterizing Breakthrough Cancer Pain Using Ecological Momentary Assessment with a Smartphone App: Feasibility and Clinical Findings
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Villegas, F, Martinez-Borba, V, Suso-Ribera, C, Castilla, D, Zaragoza, I, Garcia-Palacios, A, Ferrer, C
Background: mobile applications (apps) facilitate cancer pain ecological momentary assessment (EMA) and provide more reliable data than retrospective monitoring. The aims of this study are (a) to describe the status of persons with cancer pain when assessed ecologically, (b) to analyze the utility of clinical alarms integrated into the app, and (c) to test the feasibility of implementing an app for daily oncological pain monitoring. Methods: in this feasibility study, 21 patients (mean age = 56…
Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Garcia-Carbonero, R, Teresa, FM, Mercader-Cidoncha, E, Mitjavila-Casanovas, M, Robledo, M, Tena, I, Alvarez-Escola, C, Aristegui, M, Bella-Cueto, MR, Ferrer-Albiach, C, Hanzu, FA
Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that arise from chromaffin cells of the adrenal medulla and the sympathetic/parasympathetic neural ganglia, respectively. The heterogeneity in its etiology makes PPGL diagnosis and treatment very complex. The aim of this article was to provide practical clinical guidelines for the diagnosis and treatment of PPGLs from a multidisciplinary perspective, with the involvement of the Spanish Societies of Endocrinology and…
Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lozano, R, Lorente, D, Aragon, IM, Romero-Laorden, N, Nombela, P, Mateo, J, Reid, AHM, Cendon, Y, Bianchini, D, Llacer, C, Sandhu, SK, Sharp, A, Rescigno, P, Garces, T, Pacheco, MI, Flohr, P, Massard, C, Lopez-Casas, PP, Castro, E, de Bono, JS, Olmos, D
Simple Summary
The prognostic role of CTC enumeration in mCRPC patients has been established in several studies, demonstrating a higher prognostic performance than post-treatment changes in PSA levels in patients treated with AR signaling inhibitors, but not taxanes. We carried out a pooled analysis of two prospective studies in mCRPC patients treated with docetaxel. The results of this study showed a greater ability of early changes in circulating tumor cells (CTCs) compared to PSA response…
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lozano, R, Salles, DC, Sandhu, S, Aragon, IM, Thorne, H, Lopez-Campos, F, Rubio-Briones, J, Gutierrez-Pecharroman, AM, Maldonado, L, di Domenico, T, Sanz, A, Prieto, JD, Garcia, I, Pacheco, MI, Garces, T, Llacer, C, Romero-Laorden, N, Zambrana, F, Lopez-Casas, PP, Lorente, D, Mateo, J, Pritchard, CC, Antonarakis, ES, Olmos, D, Lotan, TL, Castro, E
Background: Intraductal (IDC) and cribriform (CRIB) histologies in prostate cancer have been associated with germline BRCA2 (gBRCA2) mutations in small retrospective series, leading to the recommendation of genetic testing for patients with IDC in the primary tumour.
Patients and methods: To examine the association of gBRCA2 mutations and other tumour molecular features with IDC and/or cribriform (CRIB) histologies, we conducted a case -control study in which primary prostate tumours from 58…
SEOM clinical guidelines for anaemia treatment in cancer patients (2020)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Alvarez, YE, Bataller, RD, Altozano, JP, Martinez, SR, Alvarez, AS, Cordellat, AB, Vazquez, EB, Jaime, JC, Escobar, IG, Zambrano, CB
Anaemia is defined by the presence of haemoglobin (Hb) levels < 13 g/dL in men and 12 g/dL in women. Up to 39% of cancer patients present it at the time of diagnosis and up to 40% have iron deficiency. Anaemia causes fatigue, functional deterioration and a reduction in the quality of life; it has also been associated with a poorer response to anti-tumour treatment and lower survival. Basic diagnostic tests for anaemia are simple and should be a routine part of clinical practice. These…
Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Griguolo, G, Serna, G, Pascual, T, Fasani, R, Guardia, X, Chic, N, Pare, L, Pernas, S, Munoz, M, Oliveira, M, Vidal, M, Llombart-Cussac, A, Cortes, J, Galvan, P, Bermejo, B, Martinez, N, Lopez, R, Morales, S, Garau, I, Manso, L, Alarcon, J, Martinez, E, Villagrasa, P, Prat, A, Nuciforo, P
Despite their recognised role in HER2-positive (HER2+) breast cancer (BC), the composition, localisation and functional orientation of immune cells within tumour microenvironment, as well as its dynamics during anti-HER2 treatment, is largely unknown. We here investigate changes in tumour-immune contexture, as assessed by stromal tumour-infiltrating lymphocytes (sTILs) and by multiplexed spatial cellular phenotyping, during treatment with lapatinib-trastuzumab in HER2+ BC patients (PAMELA trial…
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Provencio, M, Majem, M, Guirado, M, Massuti, B, de las Penas, R, Ortega, AL, Domine, M, Marse, R, Sala, MA, Paredes, A, Moran, T, Vazquez, S, Coves, J, Larriba, JLG, Sanchez, JM, Vicente, D, Farre, N, Fornos, LF, Zapata, I, Franco, F, Serna-Blasco, R, Romero, A, Isla, D
Background: Little progress has been achieved in non-small cell lung cancer (NSCLC) patients with unresectable stage III disease and new drug schemes are warranted.
Material and methods: In this open-label, single-arm, phase II trial 65 treatment-naive stage III NSCLC deemed surgically unresectable by a multidisciplinary team were treated with 2 cycles of induction cisplatin at 80 mg/m(2) every 21 days plus metronomic oral vinorelbine at 50 mg/day every Monday, Wednesday and Friday. During the…
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
del Alba, AG, Mendez-Vidal, MJ, Vazquez, S, Castro, E, Climent, MA, Gallardo, E, Gonzalez-Billalabeitia, E, Lorente, D, Maroto, JP, Arranz, JA
The treatment of advanced prostate cancer has evolved due to recent advances in molecular research and new drug development. Dynamic aberrations in the androgen receptor, DNA repair genes, PTEN-PI3K, and other pathways drive the behavior of advanced prostate cancer allowing a better selection of therapies in each patient. Tumor testing for BRCA1 and BRCA2 is recommended for patients with metastatic prostate cancer, also considering a broad panel to guide decisions and genetic counseling. In…
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Blancas, I, Olier, C, Conde, V, Bayo, JL, Herrero, C, Zarcos-Pedrinaci, I, Carabantes, F, Baena-Canada, JM, Cruz, J, Ruiz-Borrego, M
Goals of endocrine therapy for advanced breast cancer (ABC) include prolonging survival rates, maintaining the quality of life, and delaying the initiation of chemotherapy. We evaluated the effectiveness of fulvestrant as first-line in patients with estrogen receptor (ER)-positive ABC with relapse during or after adjuvant anti-estrogenic therapy in real-world settings. Retrospective, observational study involving 171 postmenopausal women with ER-positive ABC who received fulvestrant as first…
Impact of Obesity on Quality of Life, Psychological Distress, and Coping on Patients with Colon Cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Gomez, D, Jimenez-Fonseca, P, Fernandez, AM, Castellanos, PC, Arbizu, MV, Cabanes, RM, Estelles, DL, Ferreira, E, Del Rio, J, Garcia, TG, Carmona-Bayonas, A, Calderon, C
Background Despite the causal relationship between obesity and colon cancer being firmly established, the effect of obesity on the course of cancer calls for further elucidation. The objective was to assess differences in clinical-pathological and psychosocial variables between obese and nonobese individuals with colon cancer.
Materials and Methods This was a prospective, multicentric, observational study conducted from 2015-2018. The sample comprised patients with stage II-III, resected colon…
Real-life study of the effectiveness of a high calorie and high protein formula in the maintenance and improvement of nutritional state in patients with an indication of long-term enteral nutrition
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Pomar, MDB, Carrera, PS, Pinera, MAR, Orenes, AJB, Romero, LC, Hernandez, NCI, Usieto, MTO, Mas, FP, Beneitez, MV, Viveros, MM, Aguilera, CN, Alcolea, JO
The selection of the most appropriate formula in long-term home enteral nutrition is a controversial issue. Our objective was to study a high protein hypercaloric enteral nutrition formula in patients with long-term feeding (180 days).
Methods: Prospective observational multicenter real-life study with high-protein hypercaloric formula (2 kcal/ml and 20% protein). General, anthropometric, analytical and quality of life data were collected by visual analog scale of the European Quality of Life…
PAM50 HER2-enriched phenotype as a predictor of early response to neoadjuvant lapatinib plus trastuzumab HER2-positive breast cancer: Survival results of the SOLTI-PAMELA study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Pascual, T, De Las Heras, BB, Martinez, N, Oliveira, M, Simon, SP, Lopez, RL, Cabrero, IR, Alarcon, JD, de Duenas, EM, Gimenez, DM, Cao, MG, Sanchez, LMM, Murillo, SM, de Ceballos, HL, Cortes, J, Cussac, AL, Prat, A
The Impact of Frailty Screening on Radiation Treatment Modification
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Fernandez-Camacho, E, Ferrer-Ramos, C, Morilllo-Macias, V, Rodriguez-Cordon, M, Sanchez-Iglesias, A, Beato-Tortajada, I, Frances-Munoz, A, Muelas-Soria, R, Piquer-Camanes, T, Santafe-Jimenez, AI, Aznar-Tortonda, V, Ferrer-Albiach, C
Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Vicent, CH, Tudela, X, Ruiz, PM, Pedralva, V, Pastor, AJ, Ahicart, D, Novella, SR, Meneu, I, Albuixech, AM, Santamaria, MA, Fonfria, M, Fuster-Matanzo, A, Anton, SO, de Duenas, EM
Clinical impact of delays in the management of lung cancer patients in the last decade: systematic review
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Guirado, M, Martin, EF, Villar, AF, Martin, AN, Sanchez-Hernandez, A
OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized clinical trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Algara, M, Rodriguez, E, Martinez-Arcelus, FJ, Salinas, J, Sanz, X, Beato, I, Manso, A, Soler, A, Rodriguez, JR, Frias, A, Calin, A, Juan, G, Meireles, P, Flaquer, A
Determination of essential biomarkers in lung cancer: A real-world data study in Spain
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
de Juan, VC, Dols, MC, Rodriguez-Abreu, D, Carcereny, E, Cantero, A, Caro, RB, Lopez, GB, Castro, RL, Sureda, BM, del Barco, E, Campelo, MRG, Guirado, M, Herrero, CJCC, Granados, ALOO, Gonzalez-Larriba, JL, Hernandez, AS, Ojea, CG, Gonzalez, MAS, Vidal, OJJ, Pulla, MP
Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Isla, D, Arriola, E, Campelo, MRG, Marti, C, Tain, PD, Vega, ALM, Piqueras, MLB, Leon, L, Calderon, VG, Rodriguez, JMO, Majem, M, Sanchez-Hernandez, A, de la Rosa, CA, Cabellos, RA, Marti-Ciriquian, JL, Paul, AM, Cordero, MG, Mellen, AC, Baez, L, Zugazagoitia, J
Atezolizumab (ATZ) with split-doses of cisplatin plus gemcitabine in patients with locally advanced or metastatic urothelial carcinoma (SOGUG-AUREA): A multicentre, single-arm phase II trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Oria, GADV, Garcia-Carbonero, I, Esteban-Gonzalez, E, Pinto, A, Lorente, D, De Liano, AG, Ortega, EM, Colomo, LJ, Puente, J, Gonzalez, I, Fernandez, O, Anguera, G
Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Isla, D, Arriola, E, Campelo, MRG, Tain, PD, Blanco, CM, Piqueras, MMLB, Vega, ALM, Mateos, LAL, Rodriguez, JMO, Calderon, VG, Tarruella, MM, Hernandez, AS, de la Rosa, CA, Cabellos, RA, Ciriquian, JLM, Paul, AM, Perez, JLF, Mellen, AC, Baez, L, Paz-Ares, L
Second-line treatment in advanced non-squamous (NS) non-small cell lung cancer (NSCLC) patients in Spain, analyzed in the Thoracic Tumor Registry (RTT)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Costa, EC, Lorduy, AC, Dols, MC, Abreu, DR, Caro, RB, Castro, RL, Sureda, BM, del Barco, E, Guirado, M, Bosch-Barrera, J, Gonzalez-Larriba, JL, Hernandez, AS, Vidal, OJJ, Rodriguez, JMO, Martinez, JM, Granados, ALOO, Padilla, A, Bueno, MTM, Cantero, A, Pulla, MP
Dignity and psychosocial related variables in elderly advanced cancer patients
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Martin-Abreu, CM, Hernandez, R, Cruz-Castellanos, P, Fernandez-Montes, A, Lorente-Estelles, D, Lopez-Ceballos, H, Ostios-Garcia, L, Antonanzas, M, Jimenez-Fonseca, P, Garcia-Garcia, T, Calderon, C
Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): A randomized phase III study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Arjona-Sanchez, A, Cano-Osuna, MT, Gutierrez, A, Segura, JJ, Perez, E, Concepcion, V, Sanchez, S, Garcia, A, Prieto, I, Sanchez, PB, Torres, J, Ramirez, M, Prada, A, Carrasco, J, Artiles, M, Villarejo, P, Ortega, G, Boldo, E, Aranda, E, Rufian, S
Molecular Divergence upon EGFR-TKI Resistance Could Be Dependent on the Exon Location of the Original EGFR-Sensitizing Mutation
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Serna-Blasco, R, Sanchez-Herrero, E, de Lope, LR, Sanz-Moreno, S, Rodriguez-Festa, A, Ares-Trotta, D, Cruz-Bermudez, A, Franco, F, Sanchez-Hernandez, A, Campayo, MD, Garcia-Giron, C, Domine, M, Blasco, A, Sanchez, JM, Oramas, J, Bosch-Barrera, J, Sala, MA, Sereno, M, Romero, A, Provencio, M
Liquid chromatography, a valuable tool in the determination of antibiotics in biological, food and environmental samples
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Peris-Vicente, J, Peris-Garcia, E, Albiol-Chiva, J, Durgbanshi, A, Ochoa-Aranda, E, Carda-Broch, S, Bose, D, Esteve-Romero, J
The Efficacy of Animal-Assisted Therapy in Patients with Dual Diagnosis: Schizophrenia and Addiction
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Monfort, M, Benito, A, Haro, G, Fuertes-Saiz, A, Canabate, M, Baquero, A
Purpose in Life and Character Strengths as Predictors of Health Sciences Students' Psychopathology During the COVID-19 Pandemic
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Echeverria, I, Peraire, M, Penades, D, Quintero, V, Benito, A, Almodovar, I, Haro, G
Evolution of RAS Mutations in Cell-Free DNA of Patients with Tissue RAS Wild-Type Metastatic Colorectal Cancer Receiving First-Line Treatment: The PERSEIDA Study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Valladares-Ayerbes, M, Garcia-Alfonso, P, Luengo, JM, Caceres, PPP, Trujillo, OAC, Vidal-Tocino, R, Llanos, M, Ayala, BL, Miron, MLL, Salud, A, Nogueras, LC, Garcia-Carbonero, R, Safont, MJ, Ferrer, EF, Aparicio, J, Conesa, MAV, Guillen-Ponce, C, Garcia-Teijido, P, Magan, MBM, Busquier, I, Salgado, M, Vila, AL, PERSEIDA Investigators
SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021)
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Remon, J, Bernabe, R, Diz, P, Felip, E, Gonzalez-Larriba, JL, Lazaro, M, Mielgo-Rubio, X, Sanchez, A, Sullivan, I, Massutti, B
Intra-Operative Electron Radiation Therapy: An Update of the Evidence Collected in 40 Years to Search for Models for Electron-FLASH Studies
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Calvo, FA, Serrano, J, Cambeiro, M, Aristu, J, Asencio, JM, Rubio, I, Delgado, JM, Ferrer, C, Desco, M, Pascau, J
Long-term survival of glioblastoma: A systematic analysis of literature about a case
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Bonet, LGG, Piqueras-Sanchez, C, Rosello-Sastre, E, Broseta-Torres, R, de las Penas, R
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Climent, MA, Font, A, Duran, I, Puente, J, Mendez-Vidal, MJ, Saez, MI, Lobera, CS, Arija, JAA, Gonzalez-Del-Alba, A, Sanchez-Hernandez, A, Fita, MJJ, Esteban, E, Alonso-Gordoa, T, Gonzalez, BM, Maroto, P, Lazaro-Quintela, M, Cassinello-Espinosa, J, Perez-Valderrama, B, Garcias, C, Castellano, D
COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Herbst, RS, Majem, M, Barlesi, F, Carcereny, E, Chu, Q, Monnet, I, Sanchez-Hernandez, A, Dakhil, S, Camidge, DR, Winzer, L, Soo-Hoo, Y, Cooper, ZA, Kumar, R, Bothos, J, Aggarwal, C, Martinez-Marti, A
A randomized phase 2 trial to evaluate the antitumor activity of enzalutamide (EZ) and talazoparib (TALA) for the treatment of metastatic hormone-naive prostate cancer (mHNPC): ZZFIRST.
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Mateo, J, Borque, A, Castellano, DE, Castro, E, Duran, MAAC, Font, A, Lorente, D, Mellado, B, Rodriguez-Vida, A, Cuadras, M, Planas, J, Salas, IC, Cordoba, S, Gonzalez, L, de Falcon, MM, Fernandez, M, Sampayo-Cordero, M, Malfettone, A, Perez-Lopez, R, Carles, J
Multidisciplinary Thoracic Tumors Board Survey in Spain
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Massuti, B, Nadal, E, Camps, C, Carcereny, E, Cobo, M, Domine, M, Garcia-Campelo, MR, Gonzalez-Larriba, JL, Guirado, M, Hernando-Trancho, F, Rodriguez-Abreu, D, Sanchez, A, Sullivan, I, Provencio, M
First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Provencio-pulla, M, Ortega, AL, Coves, J, Franco, F, Marse, R, Domine, M, Guirado, M, Carcereny, E, Fernandez, N, Martinez, E, Blanco, R, Leon, L, Sanchez, JM, Sullivan, I, Cobo, M, Sanchez, A, Massuti, B
Durvalumab (D) plus tremelimumab (T) for the treatment of patients with progressive, refractory advanced thyroid carcinoma: The DUTHY (GETNE-T1812) trial
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Castillon, JC, Plana, M, Castelo, B, Iglesias, L, Hernando, J, Tur, RY, Baste, N, Carmona-Bayonas, A, Ruiz, S, Trigo, J, Lorenzo-Lorenzo, I, Grande, E, Lorente, D, Ugidos, L, Marquina, G, Garcia-Alvarez, A, Taberna, M, Villamayor, J, Molina-Cerrillo, J, Alonso-Gordoa, T
Spanish Multicenter Retrospective Study of Real-Life Experience of Advanced NSCLC with EGFR Exon 20 Insertions Treated With Amivantamab
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Albarran-Artahona, V, Torres-Jimenez, J, Auclin, E, Esteban-Villarrubia, J, Sanchez-Gastaldo, A, Benitez-Lopez, G, Garde-Noguera, J, Perez-Gracia, JL, Soler, J, Areses, M, Olmedo-Garcia, E, Insa, A, Torres-Martinez, A, Roa, D, Dorta, M, Cardenas, N, Laguna, JC, Teixido, C, Mezquita, L
NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Nadal, E, Cantero, A, Ortega, AL, Domine, M, Barba, A, Blasco, A, Garcia, J, Mosquera, J, Vazquez, S, Rodriguez, D, Lopez-Castro, R, Juan Vidal, O, Sanchez, A, Paz Ares, L, Hernandez, A, Iranzo, P, Diz, P, Provencio, M, Simo, M, Navarro, V, Bruna, J
A real-life study of the medium to long-term effectiveness of a hypercaloric, hyperproteic enteral nutrition formula specifically for patients with diabetes on biochemical parameters of metabolic control and nutritional status
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Pomar, MDB, Sanchez, BL, Pla, MA, Carrasco, AR, Gutierrez, LS, Arrieta, AY, Carreras, PS, Medina, SG, Soria, JBM, Miranda, MB, Martinez, MSL, Suau, OT, Usieto, MTO, Gonzalez, FV, Osinaga, JA, Echevarria, EM, Garcia-Malpartida, K
Burnout, psychopathology and purpose in life in healthcare workers during COVID-19 pandemic
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
O'Higgins, M, Rojas, LA, Echeverria, I, Rosello-Jimenez, L, Benito, A, Haro, G
Relationship of DRD5 and MAO-B VNTR polymorphisms with paranoid and antisocial personality disorders in polydrug users
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
O'Higgins, M, Benito, A, Real-Lopez, M, Gil-Miravet, I, Ochoa, E, Haro, G
Specific facial emotion recognition deficits across the course of psychosis: A comparison of individuals with low-risk, high-risk, first-episode psychosis and multi-episode schizophrenia-spectrum disorders
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Pena-Garijo, J, Lacruz, M, Masanet, MJ, Palop-Grau, A, Plaza, R, -Merino, AH, Edo-Villamon, S, Valllina, O
PSA-progression only in high-risk, metastatatic hormone-sensitive prostate cancer patients treated with abiraterone in the LATITUDE trial.
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Lorente, D, Romero, N, Lozano, R, Novella, SR, Montes, A, Mateo, J, Castro, E, Sanchez, A, Olmos, D
Profile changes in admissions to a psychiatric hospitalisation unit over 15 years (2006-2021), considering the impact of the pandemic caused by SARS-CoV-2
Repositorio: r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Peraire, M, Guinot, C, Villar, M, Benito, A, Echeverria, I, Haro, G